Tatiana I. Meshcheryakova

Tatiana I. Meshcheryakova

Auto-generated profile, based on publicly available information

Tatiana I. Meshcheryakova

St. Luka’s Clinical Research Center for Children

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2015 in Annals of Human Genetics
Verified
Journal Article
Closed access
PDF file
TMTatiana I. Meshcheryakova
Tatiana I. Meshcheryakova
RZRena A Zinchenko
Rena A Zinchenko
TVTatyana Vasilyeva
Tatyana Vasilyeva
AMAndrey Marakhonov
Andrey Marakhonov
SZSvetlana S. Zhylina
Svetlana S. Zhylina
GMGennady R. Mutovin
Gennady R. Mutovin

26 September 2023 in Epilepsy and paroxysmal conditions
Verified
Journal Article
Open access
PDF file
TKTatyana Kozhanova
Tatyana Kozhanova
SZS. S. Zhilina
S. S. Zhilina
TMT. I. Meshcheryakova
T. I. Meshcheryakova
ELE. G. Lukyanova
E. G. Lukyanova
EBE. S. Bolshakova
E. S. Bolshakova
NZNikolay Zavadenko
Nikolay Zavadenko
The article presents the clinical cases of 6 patients with epilepsy, psychomotor and speech developmental delay. The heterozygous variants of the nucleotide sequence in SPTAN1 gene were detected by whole exome sequencing. Mutations in SPTAN1 gene have been described in patients with developmental and epileptic encephalopathy 5 (ОMIM: 613477). The clinical history, electroencephalographic and magnetic resonance imaging data of our patients are similar in children with variants in SPTAN1 gene described previously. It was shown that variants in SPTAN1 gene located closer to the C-terminal region are associated with a more severe phenotype, whereas the variants near the N-region – with a milder course of the disease without structural brain anomalies. However, further research is necessary in the future to better understand genotype-phenotypic correlations in SPTAN1-associated encephalopathy.

27 April 2019 in Epilepsy and paroxysmal conditions
Verified
Journal Article
Open access
PDF file
TKTatyana Kozhanova
Tatyana Kozhanova
SZS. S. Zhilina
S. S. Zhilina
TMT. I. Mescheryakova
T. I. Mescheryakova
ELE. G. Lukyanova
E. G. Lukyanova
KOK. V. Osipova
K. V. Osipova
APA. G. Prityko
A. G. Prityko
The article presents a clinical case of severe infantile generalized idiopathic epilepsy with status-like seizures, muscular dystonia and developmental delay. The examination included a phenotypic analysis: the course of the perinatal period, the nature of seizures, cognitive and behavioral disorders; video electroencephalography, and brain MRI. Using the targeted exome sequencing of genes associated with epileptic encephalopathy (NGS), we detected a nucleotide heterozygous variant of the ALDH7A1 gene (previously not described). This mutation led to the appearance of a stop codon in position 82 of the protein p.Arg82Ter and the amino acid substitution in position 399 of the protein p.Glu399Gln. This clinical observation demonstrates the importance of DNA-based diagnosis involving the targeted exome sequencing to identify molecular defects, especially in severe neonatal drug-resistant seizures. In the case of confirmed mutations in the ALDH7A1 gene, the patient should be given vitamin B6 at the therapeutic doses for seizure relief.

11 January 2020 in Epilepsy and paroxysmal conditions
Verified
Journal Article
Open access
PDF file
TKTatyana Kozhanova
Tatyana Kozhanova
SZS. S. Zhilina
S. S. Zhilina
TMT. I. Meshheryakova
T. I. Meshheryakova
KOK. V. Osipova
K. V. Osipova
SAS. O. Ayvazyan
S. O. Ayvazyan
APA. G. Prityko
A. G. Prityko
Significance of exome sequencing for diagnosis of epilepsy in children

16 April 2020 in Epilepsy and paroxysmal conditions
Verified
Journal Article
Open access
PDF file
TKTatyana Kozhanova
Tatyana Kozhanova
SZS. S. Zhilina
S. S. Zhilina
TMT. I. Mescheryakova
T. I. Mescheryakova
ELE. G. Luk`yAnova
E. G. Luk`yAnova
KOK. V. Osipova
K. V. Osipova
APA. G. Prityko
A. G. Prityko
Autism spectrum disorders (ASDs) are a group of complex disintegrative disorders of mental development, characterized by a lack of ability to social interaction, communication, stereotyped behavior, leading to social maladaptation. We present a rare clinical case of a delay in psychomotor and speech development, specific facial dysmorphia, impaired behavior, and a detected mutation in the ADNP gene. When conducting targeted exomic sequencing, we revealed a previously undescribed variant of the nucleotide sequence in the ADNP gene (p.Ala1017fs). Mutations in the ADNP gene in a heterozygous state were described for patients with Helsmoortel-van der Aa syndrome (OMIM: # 615873). Mutations in the ADNP gene are the genetic cause of ASD in 0.17% of cases. When interpreting the data of new generation sequencing (NGS) in patients with epileptic encephalopathy, ASD, and characteristic phenotype, it is advisable to take into account that the ADNP gene is one of the key genes responsible for embryonic neurodevelopment.

28 February 2025 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
LVL.D. Vorona
L.D. Vorona
TMT.I. Meshcheryakova
T.I. Meshcheryakova
TKTatyana Kozhanova
Tatyana Kozhanova
YIYu.L. Ishutina
Yu.L. Ishutina
YSYa.S. Solovyova
Ya.S. Solovyova
APA.G. Prityko
A.G. Prityko
Diaphanospondylodysostosis is a rare genetic skeletal disorder caused by biallelic variants in the BMPER gene. The term “diaphanospondylodysostosis” includes ischiospinal dysotosis, which was previously known as a separate entity with milder clinical features. The clinical phenotype of diaphanospondylodysostosis is quite variable and some cases have been lethal in the early postnatal period. The main clinical and radiographic features of the disease are a narrow chest, segmentation defects of the spine, rib anomalies, decreased ossification of the axial skeleton and nephrogenic cysts. Authors represent a clinical case report of a newborn female with diaphanospondylodysostosis who was found to have two novel heterozygous variants in the bone morphogenetic protein endothelial progenitor-binding regulator (BMPER) gene.